Lubor Urbánek

499 total citations
23 papers, 399 citations indexed

About

Lubor Urbánek is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lubor Urbánek has authored 23 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lubor Urbánek's work include Retinoids in leukemia and cellular processes (5 papers), Estrogen and related hormone effects (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). Lubor Urbánek is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Estrogen and related hormone effects (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). Lubor Urbánek collaborates with scholars based in Czechia and Austria. Lubor Urbánek's co-authors include Dagmar Solichová, Bohuslav Melichar, Petr Solich, Lenka Kujovská Krčmová, Josef Dvořák, Radomı́r Hyšpler, Hana Kalábová, Iveta Svobodová, Hubertus Haas and Zbyněk Nový and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Analytica Chimica Acta.

In The Last Decade

Lubor Urbánek

22 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lubor Urbánek Czechia 13 163 84 67 59 58 23 399
Jing Ning China 14 165 1.0× 41 0.5× 23 0.3× 20 0.3× 64 1.1× 41 543
Christoph Nusshold Austria 12 231 1.4× 27 0.3× 31 0.5× 22 0.4× 21 0.4× 16 610
Xiangnan Xu China 14 219 1.3× 49 0.6× 34 0.5× 8 0.1× 64 1.1× 38 420
Zheng Tian China 15 407 2.5× 78 0.9× 48 0.7× 5 0.1× 66 1.1× 54 700
Alma E. Martínez Italy 10 246 1.5× 22 0.3× 28 0.4× 53 0.9× 20 0.3× 12 523
G Piasecka Poland 11 149 0.9× 26 0.3× 134 2.0× 50 0.8× 16 0.3× 24 526
Lulu Yang China 14 265 1.6× 120 1.4× 71 1.1× 13 0.2× 12 0.2× 34 628
Robert L. Thies Canada 13 216 1.3× 134 1.6× 27 0.4× 9 0.2× 46 0.8× 16 523
Fabrizió Franchi Italy 9 102 0.6× 118 1.4× 56 0.8× 8 0.1× 7 0.1× 44 463
Arthur G. Romero United States 15 238 1.5× 37 0.4× 75 1.1× 24 0.4× 17 0.3× 21 638

Countries citing papers authored by Lubor Urbánek

Since Specialization
Citations

This map shows the geographic impact of Lubor Urbánek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubor Urbánek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubor Urbánek more than expected).

Fields of papers citing papers by Lubor Urbánek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lubor Urbánek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubor Urbánek. The network helps show where Lubor Urbánek may publish in the future.

Co-authorship network of co-authors of Lubor Urbánek

This figure shows the co-authorship network connecting the top 25 collaborators of Lubor Urbánek. A scholar is included among the top collaborators of Lubor Urbánek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubor Urbánek. Lubor Urbánek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jorda, Radek, Libor Havlı́ček, Md. Mahmudul Alam, et al.. (2019). 3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models. Journal of Medicinal Chemistry. 62(9). 4606–4623. 21 indexed citations
2.
Široká, Jitka, Martina Čečková, Lubor Urbánek, et al.. (2018). LC-MS/MS method for determination of cyclin-dependent kinase inhibitors, BP-14 and BP-20, and its application in pharmacokinetic study in rat. Journal of Chromatography B. 1089. 24–32.
3.
Hényková, Eva, Hana Přikrylová Vranová, Tomáš Pospíšil, et al.. (2016). Stable isotope dilution ultra-high performance liquid chromatography–tandem mass spectrometry quantitative profiling of tryptophan-related neuroactive substances in human serum and cerebrospinal fluid. Journal of Chromatography A. 1437. 145–157. 47 indexed citations
4.
Petřík, Miloš, Chuangyan Zhai, Zbyněk Nový, et al.. (2015). In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores. Molecular Imaging and Biology. 18(3). 344–352. 43 indexed citations
5.
6.
Kalábová, Hana, et al.. (2009). Effect of comorbidity on urinary neopterin in patients with breast carcinoma. European Journal of Cancer Care. 19(3). 340–345. 4 indexed citations
7.
Krčmová, Lenka Kujovská, Lubor Urbánek, Dagmar Solichová, et al.. (2009). HPLC method for simultaneous determination of retinoids and tocopherols in human serum for monitoring of anticancer therapy. Journal of Separation Science. 32(15-16). 2804–2811. 15 indexed citations
8.
Melichar, Bohuslav, Hana Kalábová, Lenka Kujovská Krčmová, et al.. (2009). Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma.. PubMed. 29(8). 3337–46. 16 indexed citations
9.
Dvořák, Josef, Bohuslav Melichar, Radomı́r Hyšpler, et al.. (2009). Intestinal permeability, vitamin A absorption, alpha-tocopherol, and neopterin in patients with rectal carcinoma treated with chemoradiation. Medical Oncology. 27(3). 690–696. 8 indexed citations
10.
Melichar, Bohuslav, Radomı́r Hyšpler, Hana Kalábová, et al.. (2008). Gastrointestinal Permeability - a Parameter of Possible Prognostic Importance in Metastatic Colorectal Carcinoma. Pteridines. 19(1). 19–22. 5 indexed citations
11.
Melichar, Bohuslav, Josef Dvořák, Lenka Kujovská Krčmová, et al.. (2008). Intestinal Permeability and Vitamin A Absorption in Patients With Chemotherapy-Induced Diarrhea. American Journal of Clinical Oncology. 31(6). 580–584. 24 indexed citations
12.
Melichar, Bohuslav, Lubor Urbánek, Lenka Kujovská Krčmová, et al.. (2008). Urinary neopterin, hemoglobin and peripheral blood cell counts in breast carcinoma patients treated with dose-dense chemotherapy.. PubMed. 28(4C). 2389–96. 14 indexed citations
13.
Melichar, Bohuslav, Hana Kalábová, Lubor Urbánek, Eva Malířová, & Dagmar Solichová. (2007). Serial Urinary Neopterin Measurements Reflect the Disease Course in Patients with Epithelial Ovarian Carcinoma Treated with Paclitaxel/Platinum Chemotherapy. Pteridines. 18(1). 1–7. 8 indexed citations
14.
15.
Kalábová, Hana, Josef Dvořák, Radomı́r Hyšpler, et al.. (2007). Urinary Neopterin in Patients Treated with Gefitinib. Pteridines. 18(1). 95–100. 1 indexed citations
16.
Melichar, Bohuslav, et al.. (2006). Urinary Neopterin in Patients with upper Gastrointestinal, Biliary and Pancreatic Carcinomas. Pteridines. 17(1). 20–24. 10 indexed citations
17.
Melichar, Bohuslav, Lenka Kujovská Krčmová, Hana Kalábová, et al.. (2006). Urinary Neopterin in Patients with Ovarian Cancer. Pteridines. 17(4). 145–153. 23 indexed citations
18.
Urbánek, Lubor, Dagmar Solichová, Bohuslav Melichar, et al.. (2006). Optimization and validation of a high performance liquid chromatography method for the simultaneous determination of vitamins A and E in human serum using monolithic column and diode-array detection. Analytica Chimica Acta. 573-574. 267–272. 56 indexed citations
19.
20.
Melichar, Bohuslav, et al.. (2006). Urinary Neopterin in Patients with Liver Tumors. Tumori Journal. 92(4). 318–322. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing Ning Breakdown of academic impact, for papers by Christoph Nusshold Breakdown of academic impact, for papers by Xiangnan Xu Breakdown of academic impact, for papers by Zheng Tian Breakdown of academic impact, for papers by Alma E. Martínez Breakdown of academic impact, for papers by G Piasecka Breakdown of academic impact, for papers by Lulu Yang Breakdown of academic impact, for papers by Robert L. Thies Breakdown of academic impact, for papers by Fabrizió Franchi Breakdown of academic impact, for papers by Arthur G. Romero
Rankless by CCL
2026